Atomoxetine Use in Attention-Deficit/Hyperactivity Disorder and Comorbid Tic Disorder in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.
Attention-deficit/hyperactivity disorder (ADHD) is a common comorbid disease in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), in which tic-like involuntary movements are frequently seen clinical conditions. In contrast to psychostimulants, atomoxetine is considered as having minimal effects on tics. Here we report two cases with ADHD and PANDAS who were treated with atomoxetine for their ADHD and comorbid tics.
1 Child and Adolescent Psychiatry, School of Medicine, Adnan Menderes University , Aydin, Turkey .
Sevcan Karakoç
SK
Demirkaya
2 Neurology, Ataturk State Hospital , Aydin, Turkey .
Mithat
M
Demirkaya
3 Child and Adolescent Psychiatry, Erenkoy Mental Health Research and Training Hospital , İstanbul, Turkey .
Canan
C
Yusufoğlu
3 Child and Adolescent Psychiatry, Erenkoy Mental Health Research and Training Hospital , İstanbul, Turkey .
Elif
E
Akın
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder; D013290:Streptococcal Infections / Q000188:drug therapy*; D013981:Tic Disorders / Q000188:drug therapy*; D016896:Treatment Outcome
D018759:Adrenergic Uptake Inhibitors; D000069445:Atomoxetine Hydrochloride